Miami, Florida

As a burgeoning global epicenter for medical and scientific advancement, the Miami life sciences ecosystem has transformed into a premier destination for biotechnology, pharmaceutical and medical device innovation.

Miami is best known for its uniquely diverse patient population and its strategic position as the "Gateway to the Americas," facilitating seamless international clinical trials and cross-border research collaborations.

The region's infrastructure is anchored by world-class academic research institutions, most notably the University of Miami’s Miller School of Medicine and the NCI-designated Sylvester Comprehensive Cancer Center, which drive breakthroughs in oncology, neuroscience and regenerative medicine.

In the biotech and pharma sectors, Miami has attracted high-growth companies like Summit Therapeutics and Catalyst Pharmaceuticals, which leverage the city's robust venture capital landscape and specialized biomanufacturing facilities.

The local healthcare innovation scene is further bolstered by a thriving health tech startup community, focusing on AI-driven drug discovery and digital therapeutics to modernize patient care.

Moreover, Miami’s logistics backbone, featuring the first IATA-certified pharma hub at Miami International Airport, provides an unmatched advantage for the global distribution of temperature-sensitive biologics.

With a rapidly expanding STEM talent pool and a collaborative environment supported by organizations like the Beacon Council and BioFlorida, Miami is solidifying its status as a top-tier life sciences hub on the world stage.